5th Al Qassimi Women’s and Children’s Hospital International Pediatric & Pediatric Critical Care Conference

Call for Abstracts

DEADLINE OF SUBMISSION: AUGUST 30, 2025 (23:59 UAE/GST)
NOTIFICATION OF ACCEPTED ABSTRACTS: SEPTEMBER 15, 2025

The scientific committee is delighted to receive your abstracts for the 5th Al Qassimi Women’s and Children’s Hospital International Pediatric & Pediatric Critical Care Conference, taking place on 1–2 November 2025 at the prestigious Sofitel Dubai the Obelisk, UAE.

Abstracts will be peer reviewed for quality of research, educational or scientific content, logical presentation and impact on the management and treatment of common problems in Pediatrics. Participants are encouraged to show real life examples of what works and practical take-away tools & solutions.

please check your downloads folder - .docx file

ABSTRACT TOPICS:

Submissions are welcome in all topics related to Pediatric Medicine and PICU

  • Shaping the Future of Pediatrics
  • Simulation in Pediatric Education and Resuscitation
  • Child Protection and Child Abuse
  • Telemedicine in Pediatric Services
  • Novel Diagnostic Approaches in Pediatrics
  • Pediatric Behavioral and Mental Disorders
  • Pediatric Pulmonology and Updates in Ventilation
  • Advances in Pediatric Cardiology and Lab Cath
  • Pediatric Surgery
  • Metabolic and Inborn Errors of Metabolism
  • Genetics and Immunology
  • Novel Vaccinations
  • Critical Care
  • Pediatric Nursing Challenges

PRESENTER INFORMATION

  • ONLY ONE person is allowed to present the abstract. Please inform your colleagues accordingly (abstracts with multiple authors)
  • The selected Abstract Oral Presenters & Selected Poster Presenters will:
    • Get complimentary registration on the day that he/she is scheduled to present in the conference
    • Will receive a certificate of attendance and appreciation for presenting the abstract
  • Presenter must not use the session as a marketing opportunity for products/equipment
  • Travel and accommodation expenses are not covered by the conference

ABSTRACT INFORMATION

  • A maximum of 2 abstracts can be submitted.
  • Abstracts must include sufficient information for reviewers to judge the nature and significance of the topic, the adequacy of the investigative strategy, the nature of the results, and the conclusions.
  • The abstract should summarize the substantive results of the work and not merely list topics to be discussed.
  • Abstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies “in progress” will be accepted.
  • Presentation format: Accepted abstracts are scheduled as either poster or oral presentations based on relevance, best practices, case studies, and completeness of the required information submitted. Authors may submit abstracts for poster presentation only but the scientific committee will have the final decision on accepting submissions and assigning the category or presentation format.
  • Language and length: Please follow the maximum word count as indicated. Do not include names of specific individuals, institutions, pharmaceutical companies, or specific manufacturers in the body of the abstract.
  • Abstract body: At this point, no figures or tables are yet to be included in the abstract.

SUBMISSION

  • AUGUST 30, 2025 | Deadline for submission of abstracts
  • SEPTEMBER 15, 2025| Notification for accepted abstracts

Acknowledgement:

Abstract submission will be acknowledged via email. If there has been no acknowledgement received within a week of submission or if you have any additional queries, please email to Ms. Maica (maica@menaconference.com)

REMINDER: Please keep in mind that the scientific committee will make the final decision on accepting the abstract. Incomplete submission / not following the guidelines will not be considered for review

Scroll to Top